Home Carboxes 32387-96-5
32387-96-5,MFCD00555042
Catalog No.:AA007GHF

32387-96-5 | 2,3-Diphenylquinoxaline-6-carboxylic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
≥98%
in stock  
$40.00   $28.00
- +
250mg
≥98%
in stock  
$90.00   $63.00
- +
500mg
≥98%
in stock  
$168.00   $117.00
- +
1g
≥98%
in stock  
$279.00   $195.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA007GHF
Chemical Name:
2,3-Diphenylquinoxaline-6-carboxylic acid
CAS Number:
32387-96-5
Molecular Formula:
C21H14N2O2
Molecular Weight:
326.3481
MDL Number:
MFCD00555042
SMILES:
OC(=O)c1ccc2c(c1)nc(c(n2)c1ccccc1)c1ccccc1
Properties
Computed Properties
 
Complexity:
457  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
25  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
3  
XLogP3:
4.1  

Downstream Synthesis Route

[1]Roubinek;Bydzovsky;Budesinsky[CollectionofCzechoslovakChemicalCommunications,1984,vol.49,#1,p.285-294]

[2]Heravi,MajidM.;Bakhtiari,Khadijeh;Bamoharram,FatemehF.;Tehrani,MaryamH.[MonatsheftefurChemie,2007,vol.138,#5,p.465-467]

[3]Rong,Frank;Chow,Suetying;Yan,Shunqi;Larson,Gary;Hong,Zhi;Wu,Jim[BioorganicandMedicinalChemistryLetters,2007,vol.17,#6,p.1663-1666]

[4]Baek,Jong-Beom;Ferguson,JohnB.;Tan,Loon-Seng[Macromolecules,2003,vol.36,#12,p.4385-4396]

[5]Locationinpatent:experimentalpartKrishnakumar;Velmurugan;Jothivel;Swaminathan[CatalysisCommunications,2010,vol.11,#12,p.997-1002]

[6]CurrentPatentAssignee:CASEWESTERNRESERVEUNIVERSITY;THEUNIVERSITYOFTEXASSYSTEM-WO2018/145080,2018,A1Locationinpatent:Paragraph00480

[7]Locationinpatent:experimentalpartKrishnakumar,Balu;Swaminathan,Meenakshisundaram[BulletinoftheChemicalSocietyofJapan,2011,vol.84,#11,p.1261-1266]

[8]Locationinpatent:experimentalpartKrishnakumar;Swaminathan[JournalofMolecularCatalysisA:Chemical,2011,vol.350,#1-2,p.16-25]

[9]Bhushan,B.Popatkar;Gangadhar,A.Meshram[Heterocycles,2020,vol.100,#7]

[10]Aghapoor,Kioumars;Mohsenzadeh,Farshid;Shakeri,Atena;Darabi,HosseinReza;Ghassemzadeh,Mitra;Neumüller,Bernhard[JournalofOrganometallicChemistry,2013,vol.743,p.170-178]

[11]Locationinpatent:experimentalpartKrishnakumar;Swaminathan[JournalofOrganometallicChemistry,2010,vol.695,#24,p.2572-2577]

[12]Zehra[ChemischeBerichte,1890,vol.23,p.3629]

[13]Hui,Xu;Desrivot,Julie;Bories,Christian;Loiseau,PhilippeM.;Franck,Xavier;Hocquemiller,Reynald;Figadere,Bruno[BioorganicandMedicinalChemistryLetters,2006,vol.16,#4,p.815-820]

[14]CurrentPatentAssignee:GOVERNMENTOFTHEUNITEDSTATES-US6541633,2003,B1

[15]CurrentPatentAssignee:NORTHEASTAGRICULTURALUNIVERSITYINHARBIN,CHINA-CN110835321,2020,ALocationinpatent:Paragraph0101-0103

[16]Mirzazadeh,Roghieh;Asgari,MohammadS.;Barzegari,Ebrahim;Pedrood,Keyvan;Mohammadi-Khanaposhtani,Maryam;Sherafati,Maedeh;Larijani,Bagher;Rastegar,Hossein;Rahmani,Hojjat;Mahdavi,Mohammad;Taslimi,Parham;EdaM.;Gulçin,İlhami[ArchivderPharmazie,2021,vol.354,#9]

50548-43-1    32387-96-5   
2,3-diphenyl-quinoxaline-6-carboxylicaciddibenzofuran-4-ylamide 

[1]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.815-820

Literature

Title: Structure-activity relationship (SAR) studies of quinoxalines as novel HCV NS5B RNA-dependent RNA polymerase inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20070315

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:32387-96-5 Molecular Formula|32387-96-5 MDL|32387-96-5 SMILES|32387-96-5 2,3-Diphenylquinoxaline-6-carboxylic acid